Skip to main content

Book Reviews Review: Carlyn Zwarenstein's Opium Eater achieves that rare thing – a dispassionate account informed by deeply personal experience

Title
Opium Eater: The New Confessions
Author
Carlyn Zwarenstein
Genre
Non-fiction
Publisher
Nonvella
Pages
110
Price
$13.95

Earlier this year, Prince died of accidental overdose on fentanyl, a prescription opioid pain reliever. His death was only the latest high-profile case in the far-reaching issue – some have called it a crisis – of opioid use and abuse in North America. Canadians and Americans are the greatest consumers of legal opioid painkillers. Like Thomas De Quincey before her, Carlyn Zwarenstein didn't start taking opioids for their recreational side effects. She took what her doctor prescribed to treat her severe, chronic, debilitating pain from spinal arthritis. In her Confessions – a 21st-century update on De Quincey's Confessions of an English Opium-Eater (1821) – Zwarenstein achieves that rare thing: a dispassionate account informed by deeply personal experience. Readers will benefit from this measured look at the causes of our increased dependence, which doubles as a critical memoir on the relationship between opioids, creativity, and pain. This is the sixth book from Vancouver-based Nonvella, which publishes novella-length works of non-fiction readable in one sitting.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter